| Tuesday, December 10, 2019 |
| New test predicts chance of living more than a year on targeted breast cancer treatment |
DECEMBER 9, 2019
New test predicts the chance of living more than a year on targeted breast cancer treatment
by Institute of Cancer Research
New test predicts the chance of living more than a year on targeted breast cancer treatment
Breast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue). Credit: Julia Sero / the ICR, 20 ...more
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| Lymphoma patients may have new path to remission, even when CAR T therapy fails |
DECEMBER 7, 2019
Lymphoma patients may have a new path to remission, even when CAR T therapy fails
by Perelman School of Medicine at the University of Pennsylvania
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including CAR T therapy, into remission. A ...more
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| Acupuncture reduces radiation-induced dry mouth for cancer patients |
DECEMBER 6, 2019
Acupuncture reduces radiation-induced dry mouth for cancer patients
by the University of Texas M. D. Anderson Cancer Center
After receiving acupuncture treatment three days a week during the course of radiation treatment, head and neck cancer patients experienced less dry mouth, according to study results from researchers at The University of Tex ...more
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| Dangerous skin tumor now has treatment guidelines |
DECEMBER 5, 2019
Dangerous skin tumor now has treatment guidelines
by Northwestern University
It starts as a yellow or shiny bump on the eyelids, face or body that grows and doesn't go away, unlike a pimple.
The bump is sebaceous carcinoma, a cancer of the oil glands diagnosed in thousands of patients in the U.S. every year. If not removed and treated promptly, ...more
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| New treatment triggers the self-destruction of pancreatic cancer cells |
DECEMBER 2, 2019
New treatment triggers the self-destruction of pancreatic cancer cells
by Tel Aviv University
Pancreatic cancer is resistant to all current treatments. Patients have extremely poor chances of surviving for five years after being diagnosed.
A new Tel Aviv University study finds that a small molecule has the ability to induce the self-destructio ...more
|
|
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| Understanding why men get more cancer than women |
NOVEMBER 26, 2019
Understanding why men get more cancer than women
by Peter MacCallum Cancer Centre
Peter Mac-led research has shed new light on why men are more likely than women to get cancer, uncovering a new role for the X chromosome in affecting cancer risk and mortality.
While men are known to have a higher risk of developing, and dying from, cancer co ...more
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| 'Magic bullet' takes aim at pancreatic cancer |
NOVEMBER 25, 2019
'Magic bullet' takes aim at pancreatic cancer
by University of South Australia
Pancreatic cancer
Every day, more than 1200 people worldwide are told they have pancreatic cancer. Within 12 months, 80 percent of them will have succumbed to the disease.
It's one of the most lethal cancers in the world but new research from the University of S ...more
|
|
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| Anal cancer rates and mortality have risen dramatically among Americans: study |
NOVEMBER 19, 2019
Anal cancer rates and mortality have risen dramatically among Americans: study
by University of Texas Health Science Center at Houston
Rates of new anal cancer diagnoses and deaths related to human papillomavirus (HPV), the most common sexually transmitted infection, have increased dramatically over the last 15 years, according to researchers at T ...more
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| Advanced breast cancer patients denied access to life-prolonging drugs and opioids |
Nov. 18, 2019
Advanced breast cancer patients denied access to life-prolonging drugs and opioids
by European School of Oncology
Survival for patients with the most common forms of advanced breast cancer could be substantially improved if both younger and older patients had access to a group of anti-cancer drugs called CDK4/6 inhibitors, according to experts at t ...more
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| Nudge increases cancer screening orders, but patient-facing nudge needed |
NOVEMBER 15, 2019
Nudge increases cancer screening orders, but patient-facing nudge needed, too
by Perelman School of Medicine at the University of Pennsylvania
When the electronic health record is programmed to automatically flag and create orders for patients needing cancer screenings, doctors are significantly more likely to order them, a new Penn Medicine study ...more
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| The gut may be the ticket to reducing chemo's side effects |
NOVEMBER 11, 2019
The gut may be the ticket to reducing chemo's side effects
by Emily Caldwell, The Ohio State University
In a new study, scientists observed several simultaneous reactions in mice given a common chemotherapy drug: Their gut bacteria and tissue changed, their blood and brains showed signs of inflammation, and their behaviors suggested they were fati ...more
|
|
|
|
|
|
|
|
| Tuesday, December 10, 2019 |
| Researchers discover coffee drinkers could halve their risk of liver cancer |
NOVEMBER 7, 2019
Researchers discover coffee drinkers could halve their risk of liver cancer
by Queen's University
A research team from Queen's University has found that coffee drinkers have a lower risk of the most common type of liver cancer, hepatocellular carcinoma (HCC).
The results have been presented at the National Cancer Research Institute (NCRI) confer ...more
|
|
|
|
|
|
| Friday, November 1, 2019 |
| Survey reveals many Americans lack cancer prevention knowledge |
OCTOBER 31, 2019
Survey reveals many Americans lack cancer prevention knowledge
Only one in four U.S. adults report incorporating cancer prevention into their daily lives, according to the results of the American Society of Clinical Oncology 2019 National Cancer Opinion Survey.
The Harris Poll conducted the survey online on behalf of the American Society of Cli ...more
|
|
|
|
|
|
| Friday, November 1, 2019 |
| Adults 85 years and older generally fare well after colon cancer operations |
OCTOBER 29, 2019
Adults 85 years and older generally fare well after colon cancer operations
by American College of Surgeons
As people are living longer, more elderly patients are being diagnosed with age-related colon cancer, making it of increasing concern to the medical community. Another related issue is whether an operation should be suggested as a form of tre ...more
|
|
|
|
|
|
| Friday, November 1, 2019 |
| Lenalidomide may delay onset of myeloma-related bone, organ damage |
OCTOBER 28, 2019
Lenalidomide may delay onset of myeloma-related bone, organ damage
by Mayo Clinic
Lenalidomide may delay the onset of myeloma-related bone, organ damage
Credit: Mayo Clinic
The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma ...more
|
|
|
|
|
|
| Friday, November 1, 2019 |
| Sentinel lymph node biopsy has no benefits for stage zero breast cancer |
OCTOBER 24, 2019
Sentinel lymph node biopsy has no benefits for stage zero breast cancer
by Yale University
breast cancer
Three-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Karen Meaburn, Ph.D. at the NIH IRP.
Older women with a ve ...more
|
|
|
|
|
|
| Friday, November 1, 2019 |
| Study fingers new player in cancer immunity |
OCTOBER 23, 2019
Study fingers new player in cancer immunity
by Harvard Medical School
cancer
Killer T cells surround a cancer cell. Credit: NIH
The immune system must strike an exquisite balance between vanquishing infections and cancer, while at the same time restraining its activity to avoid inadvertently attacking the body's healthy tissues and organs.
T ...more
|
|
|
|
|
|
| Friday, November 1, 2019 |
| Aggressive form of breast cancer influenced by dual action of genes and RNA |
OCTOBER 22, 2019
Aggressive form of breast cancer influenced by dual action of genes and RNA
by Georgetown University Medical Center
Women with an aggressive, less-common type of breast cancer, known as triple-negative, versus a more common form of the disease, could be differentiated from each other by a panel of 17 small RNA molecules that are directly influenced ...more
|
|
|
|
|
|
| Friday, November 1, 2019 |
| The art of cancer caregiving: How art therapies benefits those caring for cancer patients |
OCTOBER 21, 2019
The art of cancer caregiving: How art therapies benefit those caring for cancer patients
by Drexel University
art painting
Credit: CC0 Public Domain
A cancer diagnosis is incredibly stressful for the person receiving the diagnosis. But those caring for the patient, both informally and formally, also experience stress, which can affect their own h ...more
|
|
|
|
|
|
| Thursday, September 19, 2019 |
| Radiation may lower potential for side effects of CAR T therapy in non-hodgkin's lymphoma |
SEPTEMBER 18, 2019
by Perelman School of Medicine at the University of Pennsylvania
Radiation may lower the potential for side effects of CAR T therapy in non-Hodgkin's lymphoma
Radiation May Lower Potential for Side Effects of CAR T Therapy in Non-Hodgkin's Lymphoma. Credit: Penn Medicine
Treating non-Hodgkin's lymphoma (NHL) patients with radiation therapy as ...more
|
|
|
|
|
|
| Thursday, September 19, 2019 |
| High-dose radiation a game changer in fighting deadly prostate cancer |
SEPTEMBER 17, 2019
by Alan Mozes, Healthday Reporter
High-dose radiation a game-changer in fighting deadly prostate cancer
(HealthDay)—In what might be a major breakthrough, researchers report that high doses of radiation dramatically prolonged survival in men battling an advanced and aggressive form of prostate cancer.
This particular type of cancer occurs wh ...more
|
|
|
|
|
|
| Thursday, September 19, 2019 |
| Delaying treatment worsens head, neck cancer outcomes |
SEPTEMBER 16, 2019
Delaying treatment worsens head, neck cancer outcomes
(HealthDay)—Delaying time to treatment initiation (TTI) beyond 60 days is associated with decreased overall survival and increased head and neck cancer recurrence, according to a study published online Sept. 12 in JAMA Otolaryngology-Head & Neck Surgery.
David Z. Liao, from the Albert Einstei ...more
|
|
|
|
|
|
| Thursday, September 19, 2019 |
| New imaging technology could 'revolutionize' cancer surgery |
SEPTEMBER 16, 2019
by University of Waterloo
New imaging technology could 'revolutionize' cancer surgery
Parsin Haji Reza works in his lab. Credit: University of Waterloo
Cancer treatment could be dramatically improved by an invention at the University of Waterloo to precisely locate the edges of tumors during surgery to remove them.
The new imaging technolog ...more
|
|
|
|
|
|
| Thursday, September 19, 2019 |
| Most American adults do not know that HPV causes oral, anal, and penile cancers |
SEPTEMBER 16, 2019
by University of Texas Health Science Center at Houston
HPV
Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domain
More than 70% of U.S. adults are unaware that human papillomavirus (HPV) causes anal, penile, and oral cancers, according to an analysis led by researchers at The U ...more
|
|
|
|
|
|
|
|
| Wednesday, July 31, 2019 |
| Researches novel triple-negative breast cancer treatments |
JULY 26, 2019
Researches novel triple-negative breast cancer treatments
by Medical University of South Carolina
Hollings clinical scholar researches novel triple-negative breast cancer treatments
Working with patients while also doing research is the dream for translational physicians. As the newest Hollings Cancer Center clinical scholar, that dream will come t ...more
|
|
|
|
|
|
| Wednesday, July 31, 2019 |
| Selinexor for multiple myeloma receives accelerated FDA approval |
JULY 24, 2019
Selinexor for multiple myeloma receives accelerated FDA approval
by H. Lee Moffitt Cancer Center & Research Institute
A first-in-class drug recently granted accelerated approval by the U.S. Food and Drug Administration (FDA) for adult patients with heavily pretreated multiple myeloma has been the subject of study at Moffitt Cancer Center for years. No ...more
|
|
|
|
|
|
|